Myriad Genetics (MYGN) Lower after JPMorgan Downgrades to Underweight
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $18.60 +0.59%
Rating Summary:
8 Buy, 15 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
8 Buy, 15 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Shares of Myriad Genetics (NASDAQ: MYGN) are down 4.8% to $26.34 after JPMorgan the stock from Neutral to Underweight with a price target of $26.00.
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Downgrades Warner Brothers Discovery (WBD) to Underperform, 'out of concern that an incipient advertising downturn put guidance at risk'
- Loop Capital Downgrades Matterport, Inc (MTTR) to Hold
- JPMorgan Downgrades Hanwha Solutions Corp (009830:KS) to Neutral
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
